We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
+42.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$177M
Cap. Flow
+$136M
Cap. Flow %
6.83%
Top 10 Hldgs %
28.11%
Holding
4,203
New
330
Increased
2,288
Reduced
1,042
Closed
109

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.4M
2
NVDA icon
NVIDIA
NVDA
+$6.62M
3
MSFT icon
Microsoft
MSFT
+$5.14M
4
EWC icon
iShares MSCI Canada ETF
EWC
+$4.46M
5
LLY icon
Eli Lilly
LLY
+$4.44M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$2.05M
2
GE icon
GE Aerospace
GE
+$1.19M
3
LIN icon
Linde
LIN
+$955K
4
K
Kellanova
K
+$804K
5
KMB icon
Kimberly-Clark
KMB
+$781K

Sector Composition

Rank Sector Weight
1 Technology 27.22%
2 Financials 12.87%
3 Consumer Discretionary 9.03%
4 Healthcare 8.77%
5 Industrials 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFU icon
3526
InfuSystem Holdings
INFU
$249M
$233 ﹤0.01%
26
RCEL icon
3527
Avita Medical
RCEL
$240M
$231 ﹤0.01%
67
-310
-82% -$1.24K
BETA
3528
Beta Technologies Inc
BETA
$5.43B
$226 ﹤0.01%
+8
New +$239
AURA icon
3529
Aura Biosciences
AURA
$826M
$223 ﹤0.01%
41
-564
-93% -$3.35K
JANX icon
3530
Janux Therapeutics
JANX
$967M
$221 ﹤0.01%
16
+8
+100% +$188
FATE icon
3531
Fate Therapeutics
FATE
$326M
$218 ﹤0.01%
+222
New +$267
IBRX icon
3532
ImmunityBio
IBRX
$8.1B
$210 ﹤0.01%
+106
New +$240
PZA icon
3533
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.26B
$209 ﹤0.01%
+9
New +$209
MQ icon
3534
Marqeta
MQ
$1.66B
$195 ﹤0.01%
10
-100
-91% -$1.92K
QURE icon
3535
uniQure
QURE
$3.22B
$191 ﹤0.01%
8
+4
+100% +$154
LZM icon
3536
Lifezone Metals
LZM
$370M
$184 ﹤0.01%
43
-8
-16% -$36
PINE
3537
Alpine Income Property Trust
PINE
$352M
$184 ﹤0.01%
11
-10
-48% -$156
PROP icon
3538
Prairie Operating Co
PROP
$78.1M
$184 ﹤0.01%
+109
New +$198
RCMT icon
3539
RCM Technologies
RCMT
$208M
$184 ﹤0.01%
+9
New +$193
BHVN icon
3540
Biohaven
BHVN
$2.21B
$181 ﹤0.01%
16
-131
-89% -$1.62K
XERS icon
3541
Xeris Biopharma Holdings
XERS
$1.45B
$181 ﹤0.01%
23
-1
-4% -$8
RBKB icon
3542
Rhinebeck Bancorp
RBKB
$194M
$180 ﹤0.01%
15
-9
-38% -$99
SNWV
3543
SANUWAVE Health Inc
SNWV
$50.6M
$179 ﹤0.01%
6
-14
-70% -$449
COOK icon
3544
Traeger
COOK
$172M
$178 ﹤0.01%
+3
New +$146
NP
3545
Neptune Insurance Holdings
NP
$4.39B
$175 ﹤0.01%
+6
New +$158
ECF
3546
Ellsworth Growth & Income Fund
ECF
$172M
$174 ﹤0.01%
15
TLRY icon
3547
Tilray
TLRY
$622M
$172 ﹤0.01%
+19
New +$232
ZIM icon
3548
ZIM Integrated Shipping Services
ZIM
$3.24B
$170 ﹤0.01%
+8
New +$134
BFIN
3549
DELISTED
BankFinancial
BFIN
$168 ﹤0.01%
14
-45
-76% -$532
SRTA
3550
Strata Critical Medical Inc
SRTA
$512M
$168 ﹤0.01%
35
-117
-77% -$566

Similar funds

GAMMA Investing's Q4 2025 Portfolio in Review

As of Q4 2025, GAMMA Investing held 4,203 positions worth $1.99B, up 9.8% from $1.81B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GAMMA Investing deployed $136M of net new capital in Q4 2025, opening 330 new positions and adding to 2,288 existing holdings. Its largest new stake was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $2.05M trimmed.

  • GAMMA Investing's largest Q4 2025 buy was iShares MSCI Canada ETF: 86,202 shares worth $4.65M.
  • GAMMA Investing added most to Apple in Q4 2025, an estimated $10.4M increase.
  • GAMMA Investing's biggest Q4 2025 reduction was JPMorgan Chase, cutting an estimated $2.05M.
  • GAMMA Investing fully exited Kellanova in Q4 2025, selling an estimated $804K.
  • GAMMA Investing's ten largest holdings make up 28% of its $1.99B portfolio in Q4 2025.
  • GAMMA Investing opened 330 new positions and closed 109 in Q4 2025.
  • GAMMA Investing's portfolio value rose 9.8% quarter-over-quarter to $1.99B.

Based on GAMMA Investing's 13F filing for Q4 2025, filed 5 Jan 2026.